TNF is a potent anti-inflammatory cytokine in autoimmune-mediated demyelination

Nature Medicine

Volumn 4, Issue 1, 1998, Pages 78-83

  Liu, Junliang ^a   Marino, Michael W ^b   Wong, Grace ^c   Grail, Dianne ^d   Dunn, Ashley ^d   Bettadapura, Jayaram ^a   Slavin, Anthony J ^a   Old, Lloyd ^b   Bernard, Claude C A ^a  

^a LA TROBE UNIVERSITY   (Australia)

^b LUDWIG INSTITUTE FOR CANCER RESEARCH   (Australia)

^c GENENTECH INC   (United States)

^d ROYAL MELBOURNE HOSPITAL   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

TUMOR NECROSIS FACTOR;

ANIMAL EXPERIMENT; ARTICLE; DEMYELINATION; GENE EXPRESSION REGULATION; GENE TARGETING; GENE THERAPY; HUMAN; IMMUNOPATHOGENESIS; INFLAMMATION; MOUSE; MULTIPLE SCLEROSIS; NONHUMAN; PRIORITY JOURNAL; PROTEIN SYNTHESIS REGULATION;

ANIMALS; CROSSES, GENETIC; FEMALE; HETEROZYGOTE; INFLAMMATION; LYMPHOCYTES; MACROPHAGES; MICE; MICE, INBRED C57BL; MICE, INBRED NOD; MICE, INBRED STRAINS; MICE, KNOCKOUT; MULTIPLE SCLEROSIS; MYELIN SHEATH; MYELIN-ASSOCIATED GLYCOPROTEIN; OLIGODENDROGLIA; RECOMBINANT PROTEINS; SPINAL CORD; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0031916192     PISSN: 10788956     EISSN: None     Source Type: Journal    
DOI: 10.1038/nm0198-078     Document Type: Article

References (26)

1. Raine, C.S. The immunology of the multiple sclerosis lesion [The Dale E. McFarlin memorial lecture]. Ann. Neural. 36, S61-S72 (1994).
2. Bernard, C.C.A. & Kerlero de Rosbo, N. Multiple sclerosis: An autoimmune disease of multifactorial etiology. Curr. Opin. Cell Biol. 4, 760-765 (1992).
3. Merrill, J.E. & Benveniste, E.N. Cytokines in inflammatory brain lesions: Helpful and harmful. Trends Neurosci. 19, 331-338 (1996).
4. Navikas, V. & Link, H. Cytokines and the pathogenesis of multiple sclerosis [Review]. J. Neurosci. Res. 45, 322-333 (1996).
5. Selmaj, K., Papierz, W., Clabinski, A. & Kohno, T. Prevention of chronic relapsing experimental autoimmune encephalomyelitis by soluble tumor necrosis factor receptor I. J. Neuroimmunol. 56, 135-141 (1995).
6. Bernard, C.C.A., et al. Myelin oligodendrocyte glycoprotein; A novel candidate autoantigen in multiple sclerosis. J. Mol. Med. 75, 77-88 (1997).
7. Marino, M.W., et al. Characterization of tumor necrosis factor deficient mice, Proc. Natl. Acad. Sci. USA 94, 8093-8098 (1997).
8. Aggarwal, B.B, & Natarajan, K, Tumor necrosis factor: Developments during the last decade. Eur. Cytokine Netw. 7; 93-124 (1996).
9. Ruddle, N.H., et al. An antibody to lymphotoxin and tumor necrosis factor prevents transfer of experimental allergic encephalomyelitis. J. Exp. Med. 172, 1193-1200 (1990).
10. Willenborg, D.O., Fordham, S., Bernard, C.C.A., Cowden, W.B. & Ramshaw, LA. IFN-γ plays a critical down-regulatory role in the induction and effector phase of myelin oligodendrocyte glycoprotein-induced autoimmune encephalomyelitis, J. Immunol. 157, 3223-3227 (1996).
11. Ichikawa, M, Johns, T.G., Liu, J. & Bernard, CCA. Analysis of the fine B cell specificity during the chronic/relapsing course of a multiple sclerosis-like disease in Lewis rats injected with the encephalitogenic myelin oligodendrocyte glycoprotein peptide 35-55. J. Immunol. 157, 919-926 (1996).
12. Pasparakis, M., Alexopoulou, L., Episkopou, V. & Kollias, G. Immune and inflammatory responses in TNFα-deficient mice: A critical requirement for TNFα in the formation of primary B cell follicles, follicular dendritic cell networks and germinal centers, and in the maturation of the humoral immune response. J. Exp. Med. 184, 1397-1411 (1996).
13. Linington, C., et al. T cells specific for the myelin oligodendrocyte glycoprotein mediate an unusual autoimmune inflammatory response in the central nervous system. Eur. I. Immunol. 23, 1364-1371 (1993).
14. Sercarz, E.E., et al. Dominance and crypticity of T cell antigenic determinants. Annu. Rev. Immunol. 11, 729-766 (1993).
15. Selmaj, K., Raine, C.S., Farooq, M., Norton, W.T. & Brosnan, C.F. Cytokine cyto- toxicity against oligodendrocytes: Apoptosis induced by lymphotoxin. J. Immunol. 147, 1522-1529 (1991).
16. Sharief, M.K. & Hentges, R. Association between tumor necrosis factor-α and disease progression in patients with multiple sclerosis. N. Engl. J. Med. 325, 467-472 (1991).
17. Paya, C.V., Leibson, P.J., Patrick, A.K. & Rodriguez, M. Inhibition of Theiler's virus-induced demyelination in vivo by tumor necrosis factor-α. Int. Immunol. 2, 909-913 (1990).
18. Jacob, C.O. & McDevitt, H.O. Tumour necrosis factor-α in murine autoimmune 'lupus' nephritis. Nature, 331, 356-358 (1988).
19. Jacob, CO., Aiso, S., Michie, S.A., McDevitt, H.O, & Acha-Orbea, H. Prevention of diabetes in nonobese diabetic mice by tumor necrosis factor (TNF): Similarities between TNF-α and interleukin 1. Proc. Natl. Acad. Sci. USA 87, 968-972 (1990).
20. Bruce, A.J., et al. Altered neuronal and microgltal responses to excitotoxic and ischemic brain injury in mice lacking TNF receptors. Nature Med. 2, 788-794 (1996).
21. Rothwell, N.J. & Luheshi, G.N. Brain TNF: Damage limitation or damaged reputation? Nature Med. 2, 746-747 (1996).
22. Liu, Z., Hsu, H., Goeddel, D.V. & Karin, M. Dissection of TNF receptor 1 effector functions: JNK activation is not linked to apoptosis while NF-κB activation prevents cell death. Cell 87, 565-576 (1996).
23. Eugster, H-P., et al. Multiple immune abnormalities in tumor necrosis factor and lymphotoxin-α double-deficient mice. Int. Immunol. 8, 23-36 (1996).
24. Lewis, M., et al. Cloning and expression of cDNAs for two distinct murine tumor necrosis factor receptors demonstrate one receptor is species specific, Proc. Natl. Acad. Sci. USA 88, 2830-2834 (1991).
25. Vanoosten, B.W., et al. Increased MRI activity and immune activation in two multiple sclerosis patients treated with the monoclonal anti-tumor necrosis factor antibody CA2. Neurology 47, 1531-1534 (1996).
26. Jayaram, B.M., Menon, K.K., Slavin, A., Reid, H. & Bernard, C.C.A. Purification of human myelin oligodendrocyte glycoprotein (MOG) produced in bacteria and Sf9 insect cells [Abstr.]. J. Neurochem. 66, S41 (1996).